D.E. Shaw & Co’s Keros Therapeutics KROS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$17.3M Buy
2025
Q1
$12.9M Buy
2024
Q4
$192K Sell
2024
Q3
$10.8M Buy
2024
Q2
$8.03M Buy
2024
Q1
$1.25M Buy
2023
Q2
Sell
2023
Q1
$1.33M Buy
2022
Q3
Sell
2022
Q2
$582K Buy
2021
Q2
Sell
2021
Q1
$1.61M Sell
2020
Q4
$3.89M Buy